BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionPFM Health Sciences, LP
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
PFM Health Sciences, LP ownership in BMRN / BioMarin Pharmaceutical Inc.

On November 14, 2025 - PFM Health Sciences, LP filed a 13F-HR form disclosing ownership of 0 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 178,319 shares of BioMarin Pharmaceutical Inc.. The current value of the position is $0 USD.

PFM Health Sciences, LP has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -100.00 0
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 178,319 178,319 9,802 0.8345
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -498,280 -100.00 0 -100.00
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 498,280 147,982 42.24 44,088 45.20 2.0768
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 350,298 190,732 119.53 30,364 95.69 1.1789
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 159,566 -150,835 -48.59 15,516 -51.70 0.6853
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 310,401 -805,548 -72.19 32,123 -66.04 1.1502
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,115,949 276,578 32.95 94,599 36.00 3.4226
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 839,371 120,876 16.82 69,559 25.57 2.6535
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 718,495 253,555 54.53 55,396 34.86 2.0714
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 464,940 464,940 41,077 1.3986
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -314,499 -100.00 0 -100.00
2021-02-19 2020-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 314,499 -385,553 -55.07 27,578 -48.22 0.9701
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 314,499 -385,553 27,578 1,019,967.3646
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 700,052 216,973 44.91 53,260 -10.61 2.4627
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 483,079 83,474 20.89 59,583 76.45 3.0905
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 399,605 -154,029 -27.82 33,767 -27.86 2.7732
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 553,634 -1,595,417 -74.24 46,810 -67.68 2.2296
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,149,051 69,663 3.35 144,846 -18.67 4.2772
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,079,388 2,079,388 178,100 3.3828
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -153,018 -100.00 0 -100.00
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 153,018 -830,108 -84.44 13,897 -83.90 0.3744
2017-05-15 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 983,126 -74,433 -7.04 86,299 -1.49 2.1609
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,057,559 334,821 46.33 87,608 31.02 2.4689
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 722,738 151,634 26.55 66,868 50.50 1.9575
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 571,104 571,104 44,432 1.3405
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 213,100 18,855 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 243,000 35.00 25,148 64.81 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 180,000 15,259 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-19 2020-12-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 371,700 29.87 32,594 49.69 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 371,700 32,594 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 286,200 21,774 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.